Data / Form D filings / ONL Therapeutics, Inc.
ONL Therapeutics, Inc.: Form D filings
ONL Therapeutics, Inc., a biotechnology company in Ann Arbor, MI, filed 10 Form D notices with the SEC between 2014 and 2024. The latest, on September 16, 2024, reports $60 million sold of a $65 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 524 S. Main St, Suite 110, Ann Arbor, MI, 48104
- Phone
- (734) 412-8787
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1611793
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | New notice | $65,000,002 | $59,999,998 | $5,000,004 | 35 | Sep 12, 2024 | sec.gov |
| Mar 12, 2024 | New notice | $10,000,000 | $9,999,948 | $52 | 35 | Feb 29, 2024 | sec.gov |
| Mar 15, 2023 | New notice | $15,000,000 | $4,999,956 | $10,000,044 | 30 | Mar 7, 2023 | sec.gov |
| Dec 30, 2020 | New notice | $47,359,054 | $26,802,122 | $20,556,932 | 44 | Dec 18, 2020 | sec.gov |
| Oct 30, 2020 | New notice | $2,000,000 | $2,000,000 | 3 | Oct 19, 2020 | sec.gov | |
| Aug 22, 2019 | New notice | $3,000,000 | $3,000,000 | 25 | Aug 15, 2019 | sec.gov | |
| Sep 21, 2018 | New notice | $1,000,000 | $639,000 | $361,000 | 14 | Sep 7, 2018 | sec.gov |
| May 19, 2017 | New notice | $4,338,067 | $2,635,567 | $1,702,500 | 19 | May 12, 2017 | sec.gov |
| Aug 10, 2016 | New notice | $1,200,000 | $916,161 | $283,839 | 11 | Aug 1, 2016 | sec.gov |
| Jun 30, 2014 | New notice | $1,000,000 | $501,810 | $498,190 | 14 | Jun 17, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Esposito | Executive Officer, Director | |
| Constance Chang | Executive Officer | |
| Aaron Fletcher | Director | |
| Michal Silverberg | Director | |
| Bill Burns | Director | |
| David Zacks | Executive Officer | |
| Marian Nakada | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Sep 16, 2024 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ONL Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.